Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 04/03/2013 Diagram showing how CARL® works: the drug is distributed in the body and part of it is removed with two filters.

    TellTargeting Medical GmbH – targeted chemotherapy using CARL®

    The needs of cancer patients are clear chemotherapies that are as gentle as possible associated with minimal adverse effects and have a rapid effect. This is often difficult to achieve because the drug that stops tumour growth needs to remain in the body for a certain amount of time during which time it damages cancerous as well as healthy structures. Dr. Gerhard Pütz and Dr. Jürgen Eckes founded the company TellTargeting Medical GmbH Co. KG…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/telltargeting-medical-gmbh-targeted-chemotherapy-using-carl
  • Article - 06/11/2017 Green and blue spheres of different sizes to show how the drug dosage showing how active ingredient and liposomes become a drug.

    HEIDELTEC: gummy bears may replace injections

    Peptide- and protein-based drugs like those used for treating diabetes, cancer and autoimmune diseases cannot be administered orally. This is because these biomolecules degrade in the gastrointestinal tract, thus preventing them from reaching their target site in the body. Protein- and peptide-base drugs therefore have to be administered by way of injection, which is comparatively complicated and painful. However, a start-up company called…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/heideltec-gummy-bears-may-replace-injections
  • Press release - 24/01/2017

    Cancer Medications Learn to Hide

    The European Research Council awards Wilfried Weber an ERC Proof of Concept Grant. Wilfried Weber, Professor of Synthetic Biology at the University of Freiburg, has received a grant of roughly €150,000 for his project “Hide and Seek with Cancer Drugs” in which he is working to improve the drugs used in cancer treatment.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/cancer-medications-learn-to-hide
  • Article - 18/08/2014 Photo of a hand holding a syringe containing a dark fluid towards a naked upper arm.

    The use of human genes as medical products

    In contrast to medications used for treating disease, gene therapy does not use chemical agents to alleviate or cure disease symptoms. Instead, it involves the introduction of a normal copy of a mutated gene to restore the function of a protein. Gene therapy could also be described as a way of restoring the body’s self-healing process. It is an extremely smart idea that enables the sustainable treatment of diseases which cannot usually be…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/the-use-of-human-genes-as-medical-products
  • Article - 11/02/2013 Schematic with two artificial liposomes. The membrane on the left contains phospholipids and the receptors are positioned far away from each other. The membrane of the liposome on the right also contains cholesterol and sphingomyelin, which makes the receptors aggregate into clusters.<br />

    Cholesterol boosts the memory of the immune system

    Cholesterol has been demonised for a long time as high cholesterol levels are seen as major risk factors for atherosclerosis myocardial infarction and gallstones. However cholesterol is an essential component of mammalian cell membranes and is required for proper membrane function. It exists in huge quantities in the human body. In addition to being essential for cell survival and hence all animal life in general cholesterol also plays a crucial…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/cholesterol-boosts-the-memory-of-the-immune-system
  • Article - 22/04/2014 Two young women wearing lab coats and looking at a plastic vial containing a red liquid.<br />

    Synthetic nanoparticles as mini-pills for the treatment of tumours

    Little is yet known about the risks and dangers of the tiny particles that play a key role in the field of nanotechnology because many applications are still under development. The technology is therefore not without controversy. However, there are promising possibilities for equipping artificial particles with new functions, such as optimizing the targeted delivery of drugs in the human body or developing a non-invasive type of cancer therapy.…

    https:////www.gesundheitsindustrie-bw.de/en/article/news/synthetic-nanoparticles-as-mini-pills-for-the-treatment-of-tumours
  • Company profile - 04/09/2017 Colour photo of Prof. Dr. François Paquet-Durand (left) and Barbara Brunnhuber (right).

    Mireca: a new drug for stopping the progression of eye diseases

    A team of researchers from several EU countries has developed a new drug that stops the progression of hereditary retinal diseases. The project partners founded a company called Mireca Medicines GmbH in the city of Tübingen to bring the drug to market.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/mireca-a-new-drug-for-stopping-the-progression-of-eye-diseases
  • Article - 12/12/2011 Core members from the team of Tübingen researchers (from left to right): Dr. Tobias Walker, Dr. rer. nat. Andrea Nolte, Cand. med. C. Makowieki, Prof. Dr. rer. nat. H-P. Wendel.

    siRNA in cancer therapy : Tübingen researchers awarded prize by the German Society of Thoracic Surgery

    Short ribonucleic acid molecules only 21 nucleotides long are providing new impulses for lung cancer treatment. A team of doctors and biologists from the University of Tübingen have been awarded a prize by the German Society of Thoracic Surgery for their research on siRNA.

    https:////www.gesundheitsindustrie-bw.de/en/article/news/sirna-in-cancer-therapy-tuebingen-researchers-awarded-prize-by-the-german-society-of-thoracic-surger
  • Press release - 20/08/2008

    Regine Peschka-Süss hopes to introduce gene therapeutic products into cells

    Some scientists have their career path totally mapped out from the beginning not so Prof. Dr. Regine Peschka-Süss from the University of Freiburg. She takes the time to re-assess whether she is on the right track and if necessary makes changes. Peschka-Süss is currently working on the optimisation of carriers for gene therapeutic compounds.

    https:////www.gesundheitsindustrie-bw.de/en/article/press-release/regine-peschka-suess-hopes-to-introduce-gene-therapeutic-products-into-cells
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • sb_theme_biopro.domain.mdr-ivdr
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2021
Website address: https://www.gesundheitsindustrie-bw.de/en/search